APA

Williams J. G., Alam M. F., Alrubaiy L., Arnott I., Clement C., Cohen D., Gordon J. N., Hawthorne A. B., Hilton M., Hutchings H. A., Jawhari A. U., Longo M., Mansfield J., Morgan J. M., Rapport F., Seagrove A. C., Sebastian S., Shaw I., Travis S. P. L. & Watkins A. (20180503). Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. : The lancet. Gastroenterology & hepatology.

Chicago

Williams John G, Alam M Fasih, Alrubaiy Laith, Arnott Ian, Clement Clare, Cohen David, Gordon John N, Hawthorne A Barney, Hilton Mike, Hutchings Hayley A, Jawhari Aida U, Longo Mirella, Mansfield John, Morgan Jayne M, Rapport Frances, Seagrove Anne C, Sebastian Shaji, Shaw Ian, Travis Simon P L and Watkins Alan. 20180503. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. : The lancet. Gastroenterology & hepatology.

Harvard

Williams J. G., Alam M. F., Alrubaiy L., Arnott I., Clement C., Cohen D., Gordon J. N., Hawthorne A. B., Hilton M., Hutchings H. A., Jawhari A. U., Longo M., Mansfield J., Morgan J. M., Rapport F., Seagrove A. C., Sebastian S., Shaw I., Travis S. P. L. and Watkins A. (20180503). Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. : The lancet. Gastroenterology & hepatology.

MLA

Williams John G, Alam M Fasih, Alrubaiy Laith, Arnott Ian, Clement Clare, Cohen David, Gordon John N, Hawthorne A Barney, Hilton Mike, Hutchings Hayley A, Jawhari Aida U, Longo Mirella, Mansfield John, Morgan Jayne M, Rapport Frances, Seagrove Anne C, Sebastian Shaji, Shaw Ian, Travis Simon P L and Watkins Alan. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. : The lancet. Gastroenterology & hepatology. 20180503.